TY - JOUR
T1 - Novel molecular interactions of acylcarnitines and fatty acids with myoglobin
AU - Chintapalli, Sree V.
AU - Jayanthi, Srinivas
AU - Mallipeddi, Prema L.
AU - Gundampati, Ravikumar
AU - Suresh Kumar, Thallapuranam Krishnaswamy
AU - Van Rossum, Damian B.
AU - Anishkin, Andriy
AU - Adams, Sean H.
N1 - Funding Information:
This work was supported by U.S. Department of Agriculture, Agricultural Research Service Project 6026-51000-010-05S and support from the Arkansas Children's Research Institute and National Institutes of Health NIDDK Grant R01DK078328-01 (to S. H. A.), pilot award funding from Sturgis Diabetes Research Funds (to S. H. A. and S. V. C.), and Arkansas Bioscience Institute, National Institutes of Health, NCI Grant 1 RO1 CA 172631 (to T. K. S. K.). The authors declare that they have no conflict of interests with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.
PY - 2016/11/25
Y1 - 2016/11/25
N2 - Previous research has indicated that long-chain fatty acids can bind myoglobin (Mb) in an oxygen-dependent manner. This suggests that oxy-Mb may play an important role in fuel delivery in Mb-rich muscle fibers (e.g. type I fibers and cardiomyocytes), and raises the possibility that Mb also serves as an acylcarnitine-binding protein. We report for the first time the putative interaction and affinity characteristics for different chain lengths of both fatty acids and acylcarnitines with oxy-Mb using molecular dynamic simulations and isothermal titration calorimetry experiments. We found that short- to medium-chain fatty acids or acylcarnitines (ranging from C2:0 to C10:0) fail to achieve a stable conformation with oxy-Mb. Furthermore, our results indicate that C12:0 is the minimum chain length essential for stable binding of either fatty acids or acylcarnitines with oxy-Mb. Importantly, the empirical lipid binding studies were consistent with structural modeling. These results reveal that: (i) the lipid binding affinity for oxy-Mb increases as the chain length increases (i.e. C12:0 to C18:1), (ii) the binding affinities of acylcarnitines are higher when compared with their respective fatty acid counterparts, and (iii) both fatty acids and acylcarnitines bind to oxy-Mb in 1:1 stoichiometry. Taken together, our results support a model in which oxy-Mb is a novel regulator of long-chain acylcarnitine and fatty acid pools in Mb-rich tissues. This has important implications for physiological fuel management during exercise, and relevance to pathophysiological conditions (e.g. fatty acid oxidation disorders and cardiac ischemia) where long-chain acylcarnitine accumulation is evident.
AB - Previous research has indicated that long-chain fatty acids can bind myoglobin (Mb) in an oxygen-dependent manner. This suggests that oxy-Mb may play an important role in fuel delivery in Mb-rich muscle fibers (e.g. type I fibers and cardiomyocytes), and raises the possibility that Mb also serves as an acylcarnitine-binding protein. We report for the first time the putative interaction and affinity characteristics for different chain lengths of both fatty acids and acylcarnitines with oxy-Mb using molecular dynamic simulations and isothermal titration calorimetry experiments. We found that short- to medium-chain fatty acids or acylcarnitines (ranging from C2:0 to C10:0) fail to achieve a stable conformation with oxy-Mb. Furthermore, our results indicate that C12:0 is the minimum chain length essential for stable binding of either fatty acids or acylcarnitines with oxy-Mb. Importantly, the empirical lipid binding studies were consistent with structural modeling. These results reveal that: (i) the lipid binding affinity for oxy-Mb increases as the chain length increases (i.e. C12:0 to C18:1), (ii) the binding affinities of acylcarnitines are higher when compared with their respective fatty acid counterparts, and (iii) both fatty acids and acylcarnitines bind to oxy-Mb in 1:1 stoichiometry. Taken together, our results support a model in which oxy-Mb is a novel regulator of long-chain acylcarnitine and fatty acid pools in Mb-rich tissues. This has important implications for physiological fuel management during exercise, and relevance to pathophysiological conditions (e.g. fatty acid oxidation disorders and cardiac ischemia) where long-chain acylcarnitine accumulation is evident.
UR - http://www.scopus.com/inward/record.url?scp=84997611035&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84997611035&partnerID=8YFLogxK
U2 - 10.1074/jbc.M116.754978
DO - 10.1074/jbc.M116.754978
M3 - Article
C2 - 27758871
AN - SCOPUS:84997611035
SN - 0021-9258
VL - 291
SP - 25133
EP - 25143
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 48
ER -